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330New-generation stent grafts for endovascular
management of thoracic pseudoaneurysms after
aortic coarctation repair
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Objective: Late thoracic aneurysmsdevelop in5% to12%of patientshavingundergoneopen repair for coarctationof the aorta
(CoA). We report our early results for thoracic endovascular aortic repair for pseudoaneurysms after CoA repair.
Methods: From 2008 to 2013, data regarding demographics, aneurysm morphology, procedure, and follow-up were
collected prospectively on all patients treated for pseudoaneurysms after CoA repair. Retrospective analysis of identiﬁed
patients was then performed.
Results: Thirteen patients (six men, seven women) were treated. Patients were a median age, 45 years (interquartile range
(IQR), 39-56; range, 27-66 years, and the median time after CoA repair to aneurysm treatment was 34 years (IQR,
24-40 years). All patients had saccular pseudoaneurysms of the aortic arch, with a median aneurysm size of 4.1 cm (IQR,
3.4-5.1 cm). The left subclavian artery (LSCA) was involved in 10 patients and was occluded at presentation in three. Four
patients had concurrent LSCA revascularization with carotid-subclavian bypass, one had aortic arch hybrid repair, and
the LSCA was intentionally covered in two patients. Patients underwent thoracic endovascular aortic repair using the
conformable TAG (6 of 13; W. L. Gore & Associates, Flagstaff, Ariz), Valiant device (4 of 13; Medtronic, Minneapolis,
Minn), and a custom-made Relay endograft with LSCA scallop (4 of 13; Bolton Medical, Barcelona, Spain). Technical
success was 100%, with satisfactory deployment of the stent grafts in all patients. There was no 30-day mortality, stroke, or
paraplegia. Median follow-up was 15 months (IQR, 9-19 months; range, 1-67 months). Two type II endoleaks from an
intercostal artery were managed conservatively, and one type Ib endoleak was treated successfully with distal stent extension.
Conclusions: In this cohort, new-generation stent grafts have good early clinical and radiologic outcomes, avoiding the
need for redo open surgery. Management of the LSCA can be tailored to individual patients with new stent graft tech-
nology. Long-term follow-up of these patients is crucial to understanding whether endovascular management of this
cohort is acceptable. (J Vasc Surg 2014;60:330-6.)Late thoracic pseudoaneurysms develop in 5% to 12%
of patients undergoing repair for coarctation of the aorta
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://dx.doi.org/10.1016/j.jvs.2014.02.050We report our early results using new-generation thoracic
stent grafts for thoracic endovascular aortic repair (TEVAR)
of the aortic arch and descending thoracic pseudoaneurysms
after CoA repair.
CoA describes the congenital narrowing of part of the
aorta. Narrowing of the isthmus around the insertion of the
arterial duct is the most common site of obstruction and
leads to thoracic CoA. CoA accounts for w7% of congen-
ital heart lesions, with an incidence of 0.3 to 0.4/1000 live
births.4 In 87% of cases, CoA is associated with one or
more cardiac anomalies, most commonly hypoplasia of
the aortic arch (49%), ventricular septal defect (49%), pat-
ent ductus arteriosus (49%), and bicuspid aortic valve
(46%).5 Almost all CoA is now identiﬁed and treated in
the early years of life.
Open surgical repair was ﬁrst described in 1945,
balloon dilation in 1982, and stent implantation in the
1990s.6-8 Surgical repair is usually performed through a
left lateral thoracotomy or median sternotomy. In recent
years, the most common method of surgical repair is resec-
tion and end-to-end anastomosis.9 Other techniques
include resection and prosthetic graft replacement, subcla-
vian ﬂap repair (ligation of the distal subclavian artery to
use the proximal portion to overlay patch the coarctation
segment), and synthetic patch aortoplasty, in which a
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placed across the coarctation segment to relieve the steno-
sis. The rationale for use of Dacron patch aortoplasty was
that avoidance of a circumferential suture line would allow
better growth at the repair site, thereby reducing the inci-
dence of restenosis.10 In recent years, increasing numbers
of patients have also been treated by endovascular methods
for the management of primary and recurrent coarctation.
Multiple reports appeared describing the development
of aortic pseudoaneurysms at the repair site related to all
methods of repair. A large study evaluating the long-term
results from 891 patients after open CoA repair 1 to
24 years previously showed 48 (5.4%) developed pseudo-
aneurysms at the site of repair; 89.6% in those undergoing
patch aortoplasty, 8.3% after end-to-end anastomosis, and
2.1% with prosthetic graft replacement.1 Pseudoaneurysm
formation is most frequent with patch aortoplasty in several
reports (24%-90%), with a spontaneous rupture rate of
31% and rupture-related mortality of 78%-100%, thereby
necessitating timely intervention.1,10,11 Redo surgery is
challenging, however, with mortality of up to 14% and sig-
niﬁcant morbidity, such as vocal cord and phrenic nerve
paralysis and bleeding requiring reoperation.1,12
As a result of these ﬁndings, the patch aortoplasty tech-
nique was abandoned at most centers in the late 1980s,
but a number of patients are presenting with anasto-
motic pseudoaneurysms secondary to a previous repair. Late
pseudoaneurysm formation is also seen with endovascular
techniques, at 43% after balloon angioplasty and 5.4% after
stent insertion.3
METHODS
The National Research Ethics Service (United King-
dom) conﬁrmed that ethical approval was not required
for this study.
Patients. Data were collected using a prospectively
maintained in-house database on all patients treated from
2008 to 2013 for pseudoaneurysms after CoA repair at the
Imperial Vascular Unit, London. Retrospective analysis of
identiﬁed patients was then performed. The unit receives
direct referrals of these patients from the adult Congenital
Heart Disease Centre at the Royal Brompton and Hare-
ﬁeld NHS Foundation Trust.
Imaging. Computed tomography (CT) images were
acquired using the Brilliance iCT 256-slice scanner (Phi-
lips Healthcare, Best, The Netherlands) in accordance with
standard clinical protocol with the following parameters:
200 mA, 120 kEV, 1-mm slice thickness, and 1024  1024
matrix. Intravenous iodinated contrast was administered in
conjunction with image acquisition, and the image series
was timed for opaciﬁcation of the aorta. Advanced soft-
ware on dedicated Extended Brilliance Workspace
3.5.0.2254 CT work stations (Philips Medical Systems)
enables multiplanar three-dimensional image reconstruc-
tion, evaluation of aortic diameters measured perpendic-
ular to aortic center line, and whole-vessel morphology to
facilitate case planning; these aspects are particularly rele-
vant for planning of custom-made scallop endografts. Forsaccular aneurysms, the aneurysm size is measured across
the whole aorta.
Operative technique. We attempt to minimize pro-
portion of aortic coverage to preserve spinal cord function,
and therefore, a single stent graft is used where possible.
Spinal cord protection with preoperative spinal drain inser-
tion is used only if the patient has undergone previous
aortic replacement, such as abdominal aortic aneurysm
repair, or if the endograft will cover a signiﬁcant length
of the aorta. Drinkwater et al13 demonstrated that spinal
cord ischemia is more likely to occur at a mean percentage
of aortic coverage of 76%, with 270 mm as the minimum
length of aortic coverage resulting in spinal cord ischemia.
All cases are performed with the patient under general
anesthesia with prophylactic intravenous antibiotics (1 g
vancomycin and 750 mg cefuroxime, unless contraindi-
cated) and 5000 U intravenous heparin, with further
administration if required to maintain an activated clotting
time of 250 to 350 seconds.
Extra-anatomical bypass, followed by stent insertion, is
usually performed as a single-stage procedure where neces-
sary to preserve circulation to the left subclavian artery
(LSCA) or left common carotid. A proximal scalloped
endograft is used when the proximal landing zone is short
(<2 cm) or there is signiﬁcant angulation of the aortic arch
and further stent graft apposition to the aortic wall would
be beneﬁcial to prevent seal failure, bird-beaking, and
migration, without the need for extra-anatomical bypass.
Intraoperative transcranial Doppler monitoring of bilateral
middle cerebral arteries is performed to monitor cerebral
embolization rates during the procedure.
A surgical groin cutdown is performed and a 22F intro-
ducer sheath placed in the common femoral artery (CFA).
Contralateral percutaneous CFA access is obtained with a
5F sheath for insertion of an imaging catheter. Pharmaco-
logical blood pressure manipulation is performed with glyc-
eryl trinitrate infusion to achieve controlled systemic
hypotension to a systolic blood pressure of <70 mm Hg
to counter the windsock effect and enable precise stent
deployment. Balloon molding of the proximal and distal
stent and any endograft overlap is performed when
required, and arch angiography using a pigtail catheter is
done to check graft position and patency of arch vessels.
After this, the mean arterial pressure is maintained
>80 mm Hg using vasopressors where required to ensure
adequate perfusion of the spinal cord.
Patients are monitored postoperatively in the high-
dependency unit (HDU) and vasopressors weaned over
24 to 48 hours, with gradual reintroduction of antihyper-
tensive medications. We aim to discharge patients on post-
operative day 3, and all patients are discharged with
prophylactic aspirin therapy for 6 weeks.
RESULTS
Thirteen patients have been treated to date using endo-
vascular techniques. Patient demographics are detailed in
Table. Two patients presented with Ortner’s syndrome:
left recurrent laryngeal nerve palsy due to compression by
Table. Patient demographics
Variablesa Value (N ¼ 13)
Female sex 7 (54)
Age at time of pseudoaneurysm repair, years 45 (39-56)
Range, years 27-66
Pseudoaneurysm size, cm 4.1 (3.4-5.1)
Aneurysm characteristics
Saccular distal aortic arch pseudoaneurysm 13
Involving origin of LSCA 7
No patent LSCA present due to use in
CoA subclavian ﬂap repair
3
Just distal to LSCA 3
Patient comorbidities
Hypertension 7
Hypercholesterolemia 2
Multiple sclerosis, in remission 2
Aortic valve with or without root
replacement
3
Bicuspid aortic valve 2
Patent ductus arteriosus ligation 1
Turner syndrome 1
Epilepsy 1
Diabetes mellitus 1
Pulmonary stenosis 1
Severe left ventricular impairment with
cardiac pacemaker
1
Revision surgery for CoA 1
Previous surgical management of post-CoA
repair pseudoaneurysm
1
Coarctation repair technique
Dacron patch plastyb 9
Subclavian ﬂap repair 2
End-to-end anastomosis 1
Extra-anatomical bypass 1
Age at time of CoA repair, years 7 (1-19)
Time to treatment of aneurysm after CoA
repair, years
34 (24-40)
CoA, Coarctation of the aorta; LSCA, left subclavian artery.
aContinuous data are shown as median (interquartile range), unless indi-
cated otherwise, and categoric data are shown as number (%) or number.
bIncludes 1 patient with Dacron (DuPont, Wilmington, Del) patch (age
18 years) then revision with interposition graft for pseudoaneurysm (age
36 years) and 1 patient with subclavian ﬂap repair (age 9 weeks), followed
by revision Dacron patchplasty (age 9 months).
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patient and 6 cm in the other. The remaining 11 patients
were asymptomatic, with the pseudoaneurysm detected
afterCoA repair surveillance imaging. Four patients had con-
current LSCA revascularization with carotid-subclavian
bypass, and one patient had an aortic arch hybrid procedure
with carotid-carotid crossover and carotid-subclavian by-
pass. The LSCA was intentionally covered in two patients
with a nondominant left vertebral artery; onewith signiﬁcant
comorbidity, including severe left ventricular impairment
and cardiac pacemaker, and the other was the ﬁrst patient
treated as part of this series in 2008.
Patients underwent TEVAR using the conformable
TAG device (6 of 13; W. L. Gore and Associates, Flag-
staff, Ariz), the Valiant device (4 of 13; Medtronic
Vascular, Minneapolis, Minn), and a custom-made Relay
endograft with LSCA scallop (3 of 13; Bolton Medical,
Barcelona, Spain). The proximal landing zone was zone2 of the thoracic aorta in 12 of 13 and zone 1 in one
patient.
Access was through a CFA surgical cutdown in 12 of
13 patients, with an iliac conduit required in one patient.
Five patients required additional percutaneous access
through the left brachial artery to obtain angiographic
images in the three patients with scallop device insertion
to ensure accurate orientation of the scallop with respect
to the LSCA and in two patients for embolization of the
covered LSCA with an Amplatzer plug (St. Jude Medical,
Minnesota, Minn). Completion angiograms revealed two
type Ia endoleaks and one type Ib endoleak, all successfully
excluded by stent extension in two patients and balloon
molding in one patient.
One stent graft was used in nine of 13 patients, with
median length of stent 130 mm (interquartile range,
100-150 mm). In patients requiring more than one stent,
the length of aortic coverage was measured along a central
luminal line on a postoperative CT aortogram (CTA).
Three patients required two stents each, with aortic
coverage lengths of 93, 100, and 126 mm. In one patient,
three stents were used due to an angulated arch and size
discrepancy between the proximal and distal landing zones,
where a type Ib endoleak resulted after deployment of the
second stent, and therefore requiring a third stent for distal
extension. The resultant aortic coverage length was
191 mm. No patients required spinal drain placement
due to the relatively short lengths of aortic coverage.
Technical success was 100%, with satisfactory deploy-
ment of the stent grafts in all patients, with no retrograde
type A dissection, stent collapse or deformation, stentmigra-
tion during deployment, or conversion to open procedure.
All patients were extubated immediately postoperatively
and monitored in the HDU for 24 to 48 hours. There was
no 30-day mortality, stroke, or paraplegia. Postoperative
complications in one patient each included carotid-to-
carotid graft infection requiring revision right-to-left carotid
bypass with long saphenous vein, lymph leak from a LSCA
revascularization neck wound requiring reexploration,
and partial visual ﬁeld defect due to left retinal artery branch
occlusion (single embolus seen on funduscopy).
Median follow-up was 15 months (interquartile range,
9-19 months; range, 1-67 months). If completion angiog-
raphy is satisfactory, our standard thoracic aortic surveillance
protocol includes CTA performed 6 weeks postoperatively.
Of the 13 surveillance CTAs performed at this time,
10 showed stable graft position with no evidence of endo-
leak or graft migration, and no further procedures were
required.
Imaging is then repeated at 1 year and at annual inter-
vals thereafter. Our experience with long-term surveillance
indicates that once the stent graft is in a stable position with
no endoleak at 1 to 3 years, a magnetic resonance aorto-
gram is acceptable thereafter, particularly in this cohort of
young patients. Evidence of type II endoleak was seen
6 weeks postoperatively in two patients, so CTA was
repeated at 6 months. Both patients had a small persistent
type II endoleak from an intercostal artery with decreasing
Fig 1. Computed tomography aortogram (CTA) reconstructions after aortic coarctation (CoA) repair of a distal aortic
arch aneurysm formation in two patients involving (A) the origin of left subclavian artery (LSCA) and (B) an angulated
arch with a signiﬁcant size discrepancy between proximal and distal landing zones. The arrow indicates the LSCA.
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annual imaging surveillance. In one patient, a type Ib endo-
leak was evident on postoperative scanning but was not
seen on the completion angiogram. This was successfully
treated with distal stent extension 3 months after the
primary procedure.
DISCUSSION
Nine of 13 patients in our cohort had undergone CoA
repair with Dacron patch plasty. In our experience these
patients present with two discrete aneurysm morphol-
ogies: aneurysmal degeneration involving the Dacron
patch or a pseudoaneurysm in the form of a saccular
blowout at the anastomotic site (Fig 1). A proposed the-
ory to explain aneurysm formation is that coarctation may
represent a diffuse aortopathy because it is associated with
subsequent aneurysm formation at the site of previous
repair and in contiguous and remote segments of the
aorta and branch arteries such as the ascending aorta
and LSCA.2 Different ways that post-CoA repair anasto-
motic aneurysms may occur include the synthetic patch
repair causing increased wall strain and substantial wall
stress opposite the patch, with aneurysm formation resulting
from progressive degeneration, pseudoaneurysms result-
ing from inﬂammation of the suture line between the
aortic wall and the Dacron patch, and degeneration of
the Dacron patch ﬁbers themselves.14,15 Studies have sug-
gested that saccular aneurysms may be more prone to
rupture than fusiform aneurysms of similar diameter and
that these post-CoA repair pseudoaneurysms have a
particularly malignant course, providing a rationale for
the repair of saccular descending thoracic aneurysms at
a smaller diameter.1,11,16
Endovascular stent implantation for management of
CoA is gaining popularity because stent therapy has resulted
in signiﬁcant angiographic improvement and gradient reduc-
tion of the coarctation with low morbidity and mortality.Forbes et al3 compared surgical, stent, and balloon angio-
plasty treatment of CoA in a multicenter study, concluding
stents have signiﬁcantly lower acute complications although
they are more likely to require planned reintervention, and
5.4% of stent patients undergoing intermediate imaging
follow-up had pseudoaneurysm formation. Prevention of
an intimal tear has been proposed as the reasonwhy stent im-
plantation may protect against later aneurysm formation
compared with other methods of repair.
A recent Cochrane review concluded there was
insufﬁcient evidence to conclude superiority with re-
gards to stent placement vs surgery for the management
of primary CoA, and United Kingdom National Insti-
tute for Health and Care Excellence (NICE) guidance
supported the use of balloon angioplasty with or
without stenting for coarctation and recoarctation in
adults and children.4,17 The literature, however, demon-
strates that postrepair pseudoaneurysm formation, along
with restenosis, remains a disadvantage of all types of
treatment and can occur several years after initial repair.
As a result of these ﬁndings, and in accordance with
the American Heart Association/American College of
Cardiology guidelines for the care of adults with con-
genital heart disease, it is mandatory that all patients un-
dergo regular follow-up and surveillance imaging after
CoA repair.18
We also treated a 42-year-old man who presented with
hemoptysis as a result of an aortobronchial ﬁstula at the site
of Dacron patchplasty CoA repair 18 years previously. The
ﬁstula involved the origin of the LSCA, and urgent
TEVAR was performed with a single Gore TAG stent
and coverage of the LSCA origin without revascularization.
He has been maintained on long-term oral antibiotic ther-
apy with no signs of graft infection. At 9 years of follow-up,
he remains well, with satisfactory stent position and no
evidence of endoleak. This case highlights an additional
post-CoA repair complication and how it was successfully
Fig 2. Angiogram shows (A) insertion and (B) deployment of the conformable TAG device (W. L. Gore and Asso-
ciates, Flagstaff, Ariz) to exclude a distal arch aneurysm. This patient previously underwent aortic coarctation (CoA)
repair with a subclavian ﬂap technique, and therefore, no patent left subclavian artery (LSCA) is present.
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ﬁeld, with no complications at 9 years of follow-up.
The results presented here compare well with the liter-
ature on endovascular management of post-CoA repair
pseudoaneurysms, which mainly comprises small case se-
ries, including:
d Ince et al19 (2003), six patients using Medtronic
Talent grafts, no 1-year intervention-related morbidity
or mortality;
d Bell et al20 (2003), ﬁve patients, all aneurysms remain
excluded at median follow-up 7 months;
d Preventza et al21 (2006), eight pseudoaneurysms with
or without restenosis using a combination of Palmaz
stents and endoluminal grafts, two reinterventions 1
and 2 years postoperatively for stent migration and
endoleak; and
d Marcheix et al22 (2007), four patients using Zenith
TX2, Cook grafts, no stent-related complications at
median follow-up 7.5 months.
These authors all reported results of the endovascular
repair of pseudoaneurysms after previous surgical repair of
CoA using ﬁrst- and second-generation thoracic stent grafts,
concluding that endovascular repair is safe, effective, and
promising, with the potential to avoid repeat open surgery.
Of note, the series by Preventza et al21 had two
patients and the series by Marcheix et al22 had one patient
presenting with left arm ischemia after coverage of LSCA,
thereby necessitating subsequent LSCA revascularization.
In 2012, Roselli et al23 reported results for 25 patients
undergoing management of post-CoA repair pseudoaneur-
ysms, but results were presented as a mixed cohort undergo-
ing treatment of primary and recurrent CoA and postrepair
complications using open, hybrid, and endovascular
methods, so no data are available for the speciﬁc subgroup
of endovascular repair of post-CoA repair pseudoaneurysms.
Preventza et al2 report the occurrence and treatment of
post-CoA repair pseudoaneurysms where they treated 70%
of patients with open surgical techniques. They managed11 patients with TEVAR and four with carotid-subclavian
bypass plus TEVAR, but again, speciﬁc outcomes for this
subgroup were not reported.
Several anatomical challenges exist in the endovascular
management of post-CoA pseudoaneurysms, which include
angulation of the aortic arch, a size discrepancy between the
proximal and distal thoracic aorta, and frequent involve-
ment of the LSCA (Fig 1). Many of these patients have a
signiﬁcant degree of tortuosity of the aortic arch after pre-
vious surgery, which can lead to signiﬁcant difﬁculty in graft
planning and placement. Careful preoperative planning and
adequate imaging is essential. The maximization of all avail-
able landing zones and accuracy of graft placement is essen-
tial given the young age of these patients. The size
discrepancy between the proximal and distal landing zone
is relevant for graft planning.
First-generation and second-generation thoracic stent
grafts have demonstrated good midterm outcomes in gen-
eral. However, inadequate sealing and stent graft conforma-
tion in angulated necks, particularly when indications are
extended to more proximal landing zones (such as that
required in this post-CoA repair cohort) have led to the
development of proximal endoleaks.24 New-generation
stent grafts, such as the conformable TAG device and
Valiant Captivia system (Medtronic Vascular), are particu-
larly useful in these settings because the stents are ﬂexible
and conformable for use in an angulated arch and tortuous
aorta and resist compression (Fig 2). The Gore device, in
particular, has a generous oversizing range, and a single
stent graft can treat a range of aortic diameters; for example,
the 26-mm-diameter stent graft can be used in an intended
aortic diameter of 19.5 mm to 24 mm. In addition, ready-
made tapered devices are available with proximal and distal
diameters of 26 mm  21 mm and 31 mm  26 mm to ac-
count for the frequent difference in diameter between the
proximal and distal landing zones, especially when address-
ing smaller aortic diameters.
More recently, we have used the Relay custom-made
devices with a scallop for the LSCA (Fig 3). The scalloped
device is useful to gain extra proximal ﬁxation distance to
Fig 3. A, An angiogram shows insertion of a custom-made Relay (Bolton Medical, Barcelona, Spain) thoracic
endograft with a scallop for the left subclavian artery (LSCA). Radiopaque markers outline the scallop and midline of
graft to ensure accurate alignment (arrow). B, The angiogram after stent deployment shows exclusion of the aneurysm,
with a patent LSCA and no evidence of endoleak.
Fig 4. A reconstruction of a computed tomography aortogram
(CTA) of the patient in Fig 1, A, is shown after a left carotid-
subclavian Dacron (DuPont, Wilmington, Del) bypass graft and
thoracic endovascular aortic repair (TEVAR) with coverage of the
left subclavian artery (LSCA) origin. The follow-up CTA shows
the aneurysm has been excluded, with no evidence of endoleak and
a patent carotid-to-subclavian bypass graft (arrow).
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tion, without the need for extra-anatomical bypass. These
are especially suitable in young patients, and we also use
these devices for the treatment of other causes of descend-
ing thoracic pseudoaneurysm formation. The stent graft is
custom-made for each patient. A reinforced scallop is posi-
tioned proximally, allowing the stent to be deployed
beyond the origin of the LSCA. Radiopaque markersoutline the scallop and midline of the graft to ensure accu-
rate alignment (Fig 3). The position of the LSCA is iden-
tiﬁed using arch angiography through a pigtail catheter
usually placed through the left brachial artery for safety,
in both left anterior oblique and right anterior oblique po-
sitions (angles calculated from preprocedural CTA data).25
With sufﬁcient lowering of blood pressure, the stent can be
deployed safely in position.
Should we be stenting young patients? There are
speciﬁc concerns with endovascular intervention in young
patients. Management of the LSCA is important we believe,
particularly in this young cohort, to reduce the riskofposterior
circulation stroke due to dominant vertebral artery coverage
and to reduce paraplegia risk if further intervention is required
for subsequent aneurysmal dilatation, which these patients
have a tendency to develop. Treatment strategies include
extra-anatomical bypass with carotid-subclavian or carotid-
carotid crossover and carotid-subclavian revascularization,
followed by stent deployment. In suitable patients, use of the
Relay custom-madedeviceswitha scallop for theLSCAavoids
extra-anatomical bypass. Appropriate management of the
LSCA provides a stable landing zone, and because there is
undiseased aorta at both the proximal and distal landing
zones, in contrast to patients with dissection or aneurysmal
disease, the risk of stent migration and type I endoleaks as a
result of future aortic dilatation should be minimized (Fig 4).
Although long-term results are awaited to evaluate the
durability of thoracic endovascular repair, particularly in
young patients, this is a similar cohort to those undergoing
TEVAR for management of aortic transection, where
midterm results have been satisfactory. Thirty-one patients
(mean age, 35 years) underwent emergency TEVAR for
traumatic aortic injury, with 100% technical and clinical
success of the procedures during the follow-up period
(mean, 26 months; range, 6-65 months) and follow-up
CTA demonstrating patent endografts with no endoleak
or graft migration.26
These young patients are at reduced risk of neurologic
injury because they have limited atherosclerotic disease,
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lization, which we monitor intraoperatively using transcra-
nial Doppler. Paraplegia is also reduced because extensive
coverage of the thoracic aorta is usually not indicated,
and single, short stent grafts are commonly used. In terms
of long-term radiation exposure, the use of magnetic reso-
nance imaging for long-term surveillance is advantageous.
CONCLUSIONS
In this cohort, new-generation stent grafts have good
early clinical and radiologic outcomes, avoiding the need
for redo open surgery. Management of the LSCA can be
tailored to individual patients with new stent graft technol-
ogy. Long-term follow-up of these patients is crucial to un-
derstanding whether endovascular management of this
cohort is acceptable.
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